G6PD deficiency: global distribution, genetic variants and primaquine therapy.
Glucose-6-phosphate dehydrogenase (G6PD) is a potentially pathogenic inherited enzyme abnormality and, similar to other human red blood cell polymorphisms, is particularly prevalent in historically malaria endemic countries. The spatial extent of Plasmodium vivax malaria overlaps widely with that of...
Main Authors: | Howes, R, Battle, K, Satyagraha, A, Baird, J, Hay, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2013
|
Similar Items
-
G6PD Deficiency. Global Distribution, Genetic Variants and Primaquine Therapy
by: Howes, R, et al.
Published: (2013) -
Spatial distribution of G6PD deficiency variants across malaria-endemic regions.
by: Howes, R, et al.
Published: (2013) -
Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.
by: Baird, J, et al.
Published: (2018) -
Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms
by: J. Kevin Baird, et al.
Published: (2018-01-01) -
Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria
by: Satyagraha, AW, et al.
Published: (2021)